These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 1514034

  • 1. Reduced natural killer cell activity in multi-drug resistant pulmonary tuberculosis.
    Ratcliffe LT, Mackenzie CR, Lukey PT, Ress SR.
    Scand J Immunol Suppl; 1992; 11():167-70. PubMed ID: 1514034
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human natural killer T cells (NKT), NK and T cells in pulmonary tuberculosis: potential indicators for disease activity and prognosis.
    Zahran WA, Ghonaim MM, Koura BA, El-Banna H, Ali SM, El-Sheikh N.
    Egypt J Immunol; 2006; 13(1):67-78. PubMed ID: 17974151
    [Abstract] [Full Text] [Related]

  • 4. NK cell activity in pulmonary tuberculosis.
    Yoneda T, Kasai M, Ishibashi J, Nishikawa K, Tokunaga T, Mikami R.
    Br J Dis Chest; 1983 Apr; 77(2):185-8. PubMed ID: 6871086
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Natural killer cell activity in multidrug-resistant pulmonary tuberculosis.
    Yildiz P, Kadakal F, Tütüncü Y, Deniz G, Gürel N, Adin S, Yilmaz V.
    Respiration; 2001 Apr; 68(6):590-4. PubMed ID: 11786713
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced natural killer cell activity in patients with pulmonary tuberculosis.
    Morikawa F, Nakano A, Nakano H, Oseko F, Morikawa S.
    Jpn J Med; 1989 Apr; 28(3):316-22. PubMed ID: 2739140
    [Abstract] [Full Text] [Related]

  • 11. [Clinical and immunological study on chronic intractable pulmonary tuberculosis--an immune spectrum in pulmonary tuberculosis].
    Yoneda T, Narita N, Mikami R, Shirai F.
    Kekkaku; 1987 Oct; 62(10):489-95. PubMed ID: 3444192
    [No Abstract] [Full Text] [Related]

  • 12. Elevated Natural Killer Cell-Mediated Cytotoxicity Is Associated with Cavity Formation in Pulmonary Tuberculosis Patients.
    Li S, Wang D, Wei P, Liu R, Guo J, Yang B, Zhang H, Lu J, Gao M, Pang Y.
    J Immunol Res; 2021 Oct; 2021():7925903. PubMed ID: 34646890
    [Abstract] [Full Text] [Related]

  • 13. The presence of CD5LOW+NK cells in normal controls and patients with pulmonary tuberculosis.
    Ishiyama T, Watanabe K, Fukuchi K, Yajima K, Koike M, Tomoyasu S, Tsuruoka N.
    Immunol Lett; 1993 Aug; 37(2-3):139-44. PubMed ID: 7505001
    [Abstract] [Full Text] [Related]

  • 14. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG, Tom C, McGregor JR, Slade L, Samlowski WE.
    Cancer Res; 1990 Sep 15; 50(18):5931-6. PubMed ID: 1975512
    [Abstract] [Full Text] [Related]

  • 15. [THE USE OF "REAMBERIN" AS BIOLOGICAL RESPONSE MODIFIER TO INCREASE THE NATURAL KILLER CELLS' CYTOTOXICITY IN PATIENTS WITH LUNG TUBERCULOSIS].
    Kholamov AI, Mirzomogomedova VG, Chernoshey DA, Lizunov ES.
    Eksp Klin Farmakol; 2015 Sep 15; 78(8):22-4. PubMed ID: 26591578
    [Abstract] [Full Text] [Related]

  • 16. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
    Treichel RS, Olken S.
    Int J Cancer; 1992 Jan 21; 50(2):305-10. PubMed ID: 1370437
    [Abstract] [Full Text] [Related]

  • 17. [Natural killer cells in patients with pulmonary tuberculosis].
    Khomenko IS, Gergert VIa, Kolodiazhnaia NS.
    Biull Eksp Biol Med; 1991 Jul 21; 112(7):76-8. PubMed ID: 1793866
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Commemorative lecture of receiving Imamura Memorial Prize. NK cell in pulmonary tuberculosis from basic and clinical point of view].
    Yoneda T.
    Kekkaku; 1996 Nov 21; 71(11):625-31. PubMed ID: 8958676
    [Abstract] [Full Text] [Related]

  • 20. [NK cell activity and counts of T-lymphocyte subsets in pulmonary tuberculosis].
    Qin J.
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Aug 21; 13(4):209-11, 254. PubMed ID: 2151030
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.